Carmeliet P - Search Results

1

Impaired arterial neointima formation in mice with disruption of the plasminogen gene.

Carmeliet P, Moons L, Ploplis V, Plow E, Collen D. Carmeliet P, et al. J Clin Invest. 1997 Jan 15;99(2):200-8. doi: 10.1172/JCI119148. J Clin Invest. 1997. PMID: 9005988 Free PMC article.

2

Generation of monoclonal antibodies against autologous proteins in gene-inactivated mice.

Declerck PJ, Carmeliet P, Verstreken M, De Cock F, Collen D. Declerck PJ, et al. Among authors: carmeliet p. J Biol Chem. 1995 Apr 14;270(15):8397-400. doi: 10.1074/jbc.270.15.8397. J Biol Chem. 1995. PMID: 7536737 Free article.

3

Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice.

Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D. Ploplis VA, et al. Among authors: carmeliet p. Circulation. 1995 Nov 1;92(9):2585-93. doi: 10.1161/01.cir.92.9.2585. Circulation. 1995. PMID: 7586361

4

Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis.

Carmeliet P, Collen D. Carmeliet P, et al. FASEB J. 1995 Jul;9(10):934-8. doi: 10.1096/fasebj.9.10.7615162. FASEB J. 1995. PMID: 7615162 Review.

5

Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in mice.

Carmeliet P, Bouché A, De Clercq C, Janssen S, Pollefeyt S, Wyns S, Mulligan RC, Collen D. Carmeliet P, et al. Ann N Y Acad Sci. 1995 Jan 17;748:367-81; discussion 381-2. doi: 10.1111/j.1749-6632.1994.tb17333.x. Ann N Y Acad Sci. 1995. PMID: 7695179 No abstract available.

6

Transgenic animals as tools for the study of fibrinolysis in vivo.

Carmeliet P, Mulligan RC, Collen D. Carmeliet P, et al. J Intern Med. 1994 Oct;236(4):455-9. doi: 10.1111/j.1365-2796.1994.tb00824.x. J Intern Med. 1994. PMID: 7931048 No abstract available.

7

Physiological consequences of loss of plasminogen activator gene function in mice.

Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC. Carmeliet P, et al. Nature. 1994 Mar 31;368(6470):419-24. doi: 10.1038/368419a0. Nature. 1994. PMID: 8133887

8

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.

Carmeliet P, Kieckens L, Schoonjans L, Ream B, van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC. Carmeliet P, et al. J Clin Invest. 1993 Dec;92(6):2746-55. doi: 10.1172/JCI116892. J Clin Invest. 1993. PMID: 8254028 Free PMC article.

9

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.

Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D. Carmeliet P, et al. J Clin Invest. 1993 Dec;92(6):2756-60. doi: 10.1172/JCI116893. J Clin Invest. 1993. PMID: 8254029 Free PMC article.

10

Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system.

Carmeliet P, Collen D. Carmeliet P, et al. Thromb Haemost. 1995 Jul;74(1):429-36. Thromb Haemost. 1995. PMID: 8578500 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

784 results

Search Page

Filters